257 related articles for article (PubMed ID: 20627597)
1. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.
Lv PC; Li HQ; Sun J; Zhou Y; Zhu HL
Bioorg Med Chem; 2010 Jul; 18(13):4606-14. PubMed ID: 20627597
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
4. Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.
Yang W; Hu Y; Yang YS; Zhang F; Zhang YB; Wang XL; Tang JF; Zhong WQ; Zhu HL
Bioorg Med Chem; 2013 Mar; 21(5):1050-63. PubMed ID: 23391364
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.
Li HQ; Yan T; Yang Y; Shi L; Zhou CF; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):305-13. PubMed ID: 19914837
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents.
Li X; Lu X; Xing M; Yang XH; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Jun; 22(11):3589-93. PubMed ID: 22572580
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Qiu KM; Wang HH; Wang LM; Luo Y; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Mar; 20(6):2010-8. PubMed ID: 22361272
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors.
Liu JJ; Zhang H; Sun J; Wang ZC; Yang YS; Li DD; Zhang F; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Oct; 20(20):6089-96. PubMed ID: 22985957
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.
Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL
Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.
Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL
Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
Lv PC; Wang KR; Li QS; Chen J; Sun J; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(3):1117-23. PubMed ID: 20056425
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
Yang XH; Xiang L; Li X; Zhao TT; Zhang H; Zhou WP; Wang XM; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(9):2789-95. PubMed ID: 22503364
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
Qian Y; Zhang HJ; Lv PC; Zhu HL
Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
